Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open Label Evaluation of Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy: A Pilot Study

NCT02726919 is registered in ClinicalTrials.gov with Pavel Klein as lead sponsor.

NCT NCT02726919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open Label Evaluation of Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy: A Pilot Study
Lead sponsor
Pavel Klein
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
June 30, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy